Henry Fechner

DVM

Consultant. Technology inventor

He is a Group leader, Department of Applied Biochemistry, Institute of Biotechnology, Technical University of Berlin.

The author of the technology of our drug candidate.

Scientific focus: Development and employment of oncolytic adenoviruses and oncolytic coxsackieviruses for treatment of cancer. Treatment of coxsackievirus and adenovirus infections by RNA interference and soluble virus receptors. Investigation of virus receptor interactions. Development and employment of Adeno-associated Virus (AAV) vectors for treatment of cardiac diseases.

Resume submission form